- Home
- AXSM vs MC Comparison
AXSM vs MC Comparison
Compare AXSM & MC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- MC
- Stock Information
- Founded
- AXSM 2012
- MC 2007
- Country
- AXSM United States
- MC United States
- Employees
- AXSM N/A
- MC N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- MC Investment Managers
- Sector
- AXSM Health Care
- MC Finance
- Exchange
- AXSM Nasdaq
- MC Nasdaq
- Market Cap
- AXSM 4.2B
- MC 5.0B
- IPO Year
- AXSM 2015
- MC 2014
- Fundamental
- Price
- AXSM $84.60
- MC $72.76
- Analyst Decision
- AXSM Strong Buy
- MC Hold
- Analyst Count
- AXSM 14
- MC 7
- Target Price
- AXSM $125.54
- MC $70.67
- AVG Volume (30 Days)
- AXSM 893.5K
- MC 644.8K
- Earning Date
- AXSM 02-18-2025
- MC 02-05-2025
- Dividend Yield
- AXSM N/A
- MC 3.33%
- EPS Growth
- AXSM N/A
- MC 3712.41
- EPS
- AXSM N/A
- MC 0.58
- Revenue
- AXSM $338,457,000.00
- MC $970,704,000.00
- Revenue This Year
- AXSM $44.77
- MC $31.73
- Revenue Next Year
- AXSM $67.70
- MC $26.38
- P/E Ratio
- AXSM N/A
- MC $124.27
- Revenue Growth
- AXSM 51.47
- MC 14.60
- 52 Week Low
- AXSM $64.11
- MC $46.24
- 52 Week High
- AXSM $105.00
- MC $81.60
- Technical
- Relative Strength Index (RSI)
- AXSM 43.66
- MC 46.65
- Support Level
- AXSM $79.19
- MC $69.70
- Resistance Level
- AXSM $87.53
- MC $76.67
- Average True Range (ATR)
- AXSM 4.37
- MC 1.74
- MACD
- AXSM -0.02
- MC -0.31
- Stochastic Oscillator
- AXSM 61.27
- MC 43.90
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About MC Moelis & Company
Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.